USANA Health Sciences Inc. - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for USANA Health Sciences Inc. for the period ended June 29, 2002. USANA develops and manufactures nutritional, personal care, and weight management products distributed via a network marketing system in the U.S., Canada, Australia, New Zealand, Hong Kong, Japan, and the U.K. The company operates five geographic segments, with the U.S. segment including direct exports to the U.K. and Japan.
Key Financial Metrics
Quarter Ended June 29, 2002 (vs. June 30, 2001):
- Net Sales: $32.1 million (up 12.1% from $28.6 million).
- Gross Profit: $23.7 million (73.9% margin, up from 70.8%).
- Net Earnings: $1.7 million (up 250% from $0.5 million).
- Diluted EPS: $0.16 (up from $0.05).
- Operating Cash Flow: Not explicitly stated for the quarter, but six-month operating cash flow was $6.9 million.
Six Months Ended June 29, 2002 (vs. June 30, 2001):
- Net Sales: $60.7 million (up 8.0% from $56.2 million).
- Gross Profit: $44.6 million (73.5% margin, up from 70.9%).
- Net Earnings: $2.9 million (up 196% from $1.0 million).
- Diluted EPS: $0.28 (up from $0.10).
- Operating Cash Flow: $6.9 million (up from $6.2 million).
- Cash and Equivalents: $4.5 million (up from $2.5 million at year-end 2001).
- Debt: Total debt outstanding was $7.9 million ($7.0 million term loan + $0.9 million line of credit).
- Working Capital: $2.1 million (up from $0.35 million).
Material Changes vs. Prior Period
- Revenue Growth: Driven by a substantial increase in Associate enrollments and the launch of operations in Japan (Q4 2001). Foreign currency fluctuations had a mixed impact: positive in the quarter (+$0.2M) but negative for the six-month period (-$0.1M).
- Margin Expansion: Gross profit margins improved due to procurement efficiencies, a price increase in the Australia-New Zealand market, and higher-margin sales in Japan. This was partially offset by a higher mix of lower-margin sales aids and starter kits.
- Expense Management: Selling, General, and Administrative (SG&A) expenses decreased as a percentage of sales (26.7% for the quarter, 27.4% for six months) despite absolute increases due to variable costs and initial investments in the Taiwan market.
- Interest Expense: Decreased significantly ($114k for the quarter, $275k for six months) due to lower interest rates and reduced debt levels.
- Share Repurchases: The company repurchased 182,000 shares in the second quarter of 2002 under its existing program.
Guidance, Outlook, and Risks
Outlook and Commentary:
- Management expects modest improvement in gross profit margins in Q3 2002.
- Associate incentives as a percentage of sales are expected to trend higher as the Japan market matures, though this may be offset by the opening of the Taiwan market in Q4 2002.
- SG&A expenses are expected to be pressured in Q3 2002 due to costs associated with establishing operations in Taiwan.
- Liquidity is considered sufficient for foreseeable needs, supported by cash balances and an $11.6 million available line of credit.
Risks and Contingencies:
- Foreign Currency: Significant exposure to currency fluctuations (CAD, AUD, NZD, HKD, JPY, GBP, EUR) with no hedging instruments in place as of June 29, 2002.
- Market Expansion: Risks related to expansion into international markets and the ability to attract/maintain Associates.
- Regulatory: Rigorous government scrutiny of network marketing practices and product regulations.
- Key Personnel: Reliance on CEO/Chairman Myron W. Wentz, Ph.D. (Note: David A. Wentz was named President on July 12, 2002).
- Inventory: Increased allowance for inventory obsolescence ($1.56 million) attributed to anticipated inventory buildup for new markets not yet meeting sales expectations.
Investor Verification Checklist
- Verify the sustainability of the 12.1% quarterly revenue growth and the contribution of the new Japan market.
- Monitor the impact of the Taiwan market launch (Q4 2002) on SG&A expenses and cash flow.
- Assess the risk of foreign currency fluctuations given the lack of hedging and 45.8% of sales coming from outside the U.S.
- Review the trend in inventory obsolescence allowances as new markets mature.
- Confirm compliance with debt covenants, particularly as the line of credit expires on September 1, 2002.